Regeneron (RGO) Financial Statements
Regeneron Financial Overview
Regeneron's market cap is currently $85.24B. The company's EPS TTM is $46.95; its P/E ratio is 19.76; and it has a dividend yield of 0.39%. Regeneron is estimated to report earnings on January 29, 2027, and the estimated EPS forecast is $21.64. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.34B | $ 14.20B | $ 13.12B | $ 12.17B | $ 16.07B |
| Gross Profit | $ 12.24B | $ 12.23B | $ 10.87B | $ 10.47B | $ 13.35B |
| Operating Income | $ 3.58B | $ 3.99B | $ 4.35B | $ 5.39B | $ 8.95B |
| EBITDA | $ 5.82B | $ 5.32B | $ 4.69B | $ 5.26B | $ 9.67B |
| Net Income | $ 4.50B | $ 4.41B | $ 3.95B | $ 4.34B | $ 8.08B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.61B | $ 9.01B | $ 10.84B | $ 7.74B | $ 5.69B |
| Total Assets | $ 40.56B | $ 37.76B | $ 33.08B | $ 29.21B | $ 25.43B |
| Total Debt | $ 2.71B | $ 2.70B | $ 2.70B | $ 2.70B | $ 2.70B |
| Net Debt | $ -412.20M | $ 216.20M | $ -27.10M | $ -404.50M | $ -185.90M |
| Total Liabilities | $ 9.30B | $ 8.41B | $ 7.11B | $ 6.55B | $ 6.67B |
| Stockholders' Equity | $ 31.26B | $ 29.35B | $ 25.97B | $ 22.66B | $ 18.77B |
| Cash Flow | |||||
| Free Cash Flow | $ 4.08B | $ 3.66B | $ 3.67B | $ 4.42B | $ 6.53B |
| Operating Cash Flow | $ 4.98B | $ 4.42B | $ 4.59B | $ 5.01B | $ 7.08B |
| Investing Cash Flow | $ -629.10M | $ -2.47B | $ -3.19B | $ -3.78B | $ -5.38B |
| Financing Cash Flow | $ -3.72B | $ -2.20B | $ -1.79B | $ -1.01B | $ -1.01B |
Currency in USD